Company Search:
Advanced Search
Sponsored Links
Immutep Ltd Company Snapshot
Immutep Ltd operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Immutep Ltd with three other companies in this sector in AUSTRALIA : Cellmid Limited (2019 sales of 7.47 million Australian Dollars [US$5.19 million] ), Imugene Limited (4.54 million Australian Dollars [US$3.16 million] of which 100% was Health technologies), and Holista Colltech Limited (7.27 million Australian Dollars [US$5.05 million] ).

Sales Analysis. During the year ended June of 2019, sales at Immutep Ltd were A$6.03 million (US$4.20 million). This is a decrease of 14.2% versus 2018, when the company's sales were A$7.03 million. Contributing to the drop in overall sales was the 17.7% decline in Cancer Immunotherapy, from A$6.85 million to A$5.64 million. . However, these declines were partially offset by the increase in sales of Unallocated (up 270.7% to A$1.85 million) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Immutep Ltd
  Stock Performance Chart for Immutep Ltd
  Stock Data: Recent Stock Performance:
  Current Price (7/10/2020): .16
(Figures in Australian Dollars)
1 Week -3.1%   13 Weeks 3.3%  
4 Weeks 14.8%   52 Weeks -32.6%  
Immutep Ltd Key Data:
  Ticker: IMM Country: Australia
  Exchanges: ASX Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2019 Sales 6,034,492
(Year Ending Jan 2020).
Employees: 19
  Currency: Australian Dollars Market Cap: 60,263,629
  Fiscal Yr Ends: June Shares Outstanding: 388,797,604
  Share Type: Ordinary Closely Held Shares: 31,251,151
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.